RECURSION PHARMACEUTICALS, INC. | Business Contracts

Registration Rights Agreement, dated October 24, 2022, by and among the Company and the Purchasers (Filed With SEC on October 25, 2022)

American Institute of Architects Agreement by and between Engage Contracting Inc. and Registrant dated May 4, 2022 (Filed With SEC on August 9, 2022)

Office Lease by and between Berrueta Family, L.P. and Registrant, dated July 27, 2015, as amended (Filed With SEC on August 9, 2022)

Bayer Collaboration Expansion Agreement (Filed With SEC on March 23, 2022)

2016 Equity Incentive Plan, as amended, and forms of agreement thereunder (Filed With SEC on April 12, 2021)

Amended and Restated License Agreement between the Registrant and University of Utah Research Foundation, dated February 9, 2016 (Filed With SEC on March 22, 2021)

Stock Purchase Agreement, dated October 24, 2022, by and among the Company and the Purchasers (Filed With SEC on October 25, 2022)

Office Lease by and between Vestar Gateway, LLC and Registrant, dated November 13, 2017, as amended (Filed With SEC on August 9, 2022)

Office Lease by and between Constantine Enterprises, Inc and Registrant, dated May 1, 2022 (Filed With SEC on May 10, 2022)

Office Lease by and between Vestar Gateway, LLC and Registrant, dated November 13, 2017, as amended (Filed With SEC on May 10, 2022)

Office Lease by and between Vestar Gateway, LLC and Registrant, dated November 13, 2017, as amended (Filed With SEC on March 23, 2022)

Description of Securities (Filed With SEC on March 23, 2022)

Lease Agreement by and between Industry Office SLC, LLC and Registrant, dated February 10, 2021, as amended (Filed With SEC on March 23, 2022)

Roche Collaboration and License Agreement (Filed With SEC on March 23, 2022)

Office Lease by and between Vestar Gateway, LLC and Registrant, dated November 13, 2017, as amended (Filed With SEC on August 13, 2021)

Equity Exchange Right Agreement dated April 20, 2021 among the Registrant, Christopher Gibson, Ph.D., and the Gibson Family Trust (Filed With SEC on May 12, 2021)

Exchange Agreement dated April 20, 2021 among the Registrant, Christopher Gibson, Ph.D., and the Gibson Family Trust (Filed With SEC on May 12, 2021)

Form of Equity Exchange Right Agreement among the Registrant, Christopher Gibson, Ph.D., and entities affiliated with Dr. Gibson (Filed With SEC on April 12, 2021)

Form of Exchange Agreement among the Registrant, Christopher Gibson, Ph.D., and entities affiliated with Dr. Gibson (Filed With SEC on April 12, 2021)

2021 Employee Stock Purchase Plan and forms of agreements thereunder, to be in effect upon the completion of this offering (Filed With SEC on April 12, 2021)

2021 Equity Incentive Plan and forms of agreements thereunder, to be in effect upon the completion of this offering (Filed With SEC on April 12, 2021)

Form of Underwriting Agreement (Filed With SEC on April 12, 2021)

Specimen Class A common stock certificate of the Registrant (Filed With SEC on March 22, 2021)

Outside Director Compensation Policy (Filed With SEC on March 22, 2021)

Form of Indemnification Agreement between the Registrant and each of its directors and executive officers (Filed With SEC on March 22, 2021)

Confirmatory Employment Letter between the Registrant and Christopher Gibson, Ph.D (Filed With SEC on March 22, 2021)

Confirmatory Employment Letter between the Registrant and Ramona Doyle (Filed With SEC on March 22, 2021)

Confirmatory Employment Letter between the Registrant and Tina Marriott Larson (Filed With SEC on March 22, 2021)

Confirmatory Employment Letter between the Registrant and Michael Secora (Filed With SEC on March 22, 2021)

Confirmatory Employment Letter between the Registrant and Shafique Virani (Filed With SEC on March 22, 2021)

Executive Change in Control and Severance Plan (for executives other than the CEO) (Filed With SEC on March 22, 2021)

Office Lease by and between Vestar Gateway, LLC and Registrant, dated November 13, 2017, as amended (Filed With SEC on March 22, 2021)

CEO Executive Change in Control and Severance Plan (Filed With SEC on March 22, 2021)

Amended and Restated Lease by and between Berrueta Family L.P. and Mousera, Inc. dated July 27, 2015, as amended June 2017 and assigned to Registrant on August 16, 2019 (Filed With SEC on March 22, 2021)

Research Collaboration and Option Agreement by and between Bayer AG and the Registrant, dated August 28, 2020 (Filed With SEC on March 22, 2021)

Exclusive License Agreement between Ohio State Innovation Foundation and Registrant, dated December 21, 2018 (Filed With SEC on March 22, 2021)

License Agreement by and between Takeda Pharmaceutical Company Limited and Registrant, dated May 1, 2020 (Filed With SEC on March 22, 2021)

Lease Agreement by and between Industry Office SLC, LLC and Registrant, dated February 10, 2021 (Filed With SEC on March 22, 2021)

Credit and Security Agreement by and among MidCap Financial Trust, as administrative agent, and the lenders party thereto, dated September 18, 2019 (Filed With SEC on March 22, 2021)

Executive Incentive Compensation Plan (Filed With SEC on March 22, 2021)

Amended and Restated Investors Rights Agreement by and among the Registrant and certain of its stockholders, dated September 1, 2020 (Filed With SEC on March 22, 2021)

RECURSION PHARMACEUTICALS, INC. (41)